Advertisement

Bone Marrow

  • Sandra Doyle
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)

Keywords

Disseminate Intravascular Coagulation Invasive Aspergillosis Disseminate Intravascular Coagulation Graft Versus Host Disease Platelet Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman, M.H. (1994). The systemic inflammatory response, sepsis, and multiple organ dysfunction: New definitions for an old problem. Critical Care Nursing Clinics of North American, 6:243–250Google Scholar
  2. Ackerman, M.H., Evans, N.J., Ecklund, M.M. (1994). Systemic infiammatory response syndrome, sepsis, and nutritional support. Critical Care Nursing Clinics of North America, 6:321–340PubMedGoogle Scholar
  3. Alcorta, I, Perira, A., Ordinas, A. (1996). Clinical and laboratory factors associated with platelet transfusion refractoriness: a case control study. British Journal of Haematology, 93:220–224PubMedGoogle Scholar
  4. Alexander, S.A., Walsh, T.J., Freifeld, A.G, et al. (2002). Infectious complications in pediatric cancer patients. In Pizzo P.A., Poplack D.G. (eds), Principles and Practices of Pediatric Oncology, 4th edn., pp. 1239–1283. Philadelphia: Lippincott Williams & WilkinsGoogle Scholar
  5. American Academy of Pediatrics. (2003). Summary of infectious diseases. In Pickering, L.K. (ed.). Red Book: 2003 Report of the Committee on Infectious Diseases, 26th edn. pp. 189–690. Elk Grove Village, IL: American Academy of PediatricsGoogle Scholar
  6. American Association of Blood Banks. (1997). Recommendations of AABB on use of CMV safe blood. Association Bulletin 97-2, AprilGoogle Scholar
  7. Baehner, R.L., Neiberger, R.G., Johnson, D.G., et al. (1973). Transient bacterial defect of peripheral blood phagocytes form children with acute lymphoblastic leukemia receiving craniospinal irradiation. New England Journal of Medicine, 289:1209–1219PubMedGoogle Scholar
  8. Bick, R.L. (1994). Disseminated intravascular coagulation. Objective criteria for the diagnosis and management. Medical Clinics of North America, 578:511–543Google Scholar
  9. Bick, R.L. (1996). Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment and assessment of therapeutic response. Seminars in Thrombosis and Hemostasis, 22:69–88PubMedGoogle Scholar
  10. Bodey, G.P., Buckley, M., Sate, Y.S., et al. (1966). Quantitative relationship between circulating lymphocytes and infection in patients with acute leukemia. Annals of Internal Medicine, 64:328–30PubMedGoogle Scholar
  11. Brown, K.K.(1994). Septic shock. American Journal of Nursing, 94, 94(10):21–22Google Scholar
  12. Bruce, J.L., Grove, S.K. (1992). Fever: pathology and treatment. Critical Care Nurse, 12(1):40–49Google Scholar
  13. Chalmers, E., Gibson, B.E. (1999). Acquired disorder of hemostasis during childhood. In Lilleyman J.S., Hann I.M., Blanchette V.S. (eds) Pediatric Hematology, 2nd edn., pp. 629–649. London: Churchill LivingstoneGoogle Scholar
  14. Chanock, S.J., Gorlin, J.B. (1996). Granulocyte transfusions. Time for a second look. Infectious Diseases Clinics of North America, 10:327–343Google Scholar
  15. Chuansumrit, A., Hotrakitay, S., Hathirat, P., et al. (1993). Disseminated intravascular coagulation in children: diagnosis, management and outcome. Southeast Asian Journal of Tropical Medicine and Public Health, 24:229–233PubMedGoogle Scholar
  16. Dale, D. (2003). Myeloid disorders. In George J.N., Williams M.E. (eds) ASH-SAP American Society of Hematology Self Assessment Program, pp.116–128. Massachusetts: BlackwellGoogle Scholar
  17. Dale, D.C., Peterdorf, R.G. (1973). Corticosteroids and infectious disease. Medical Clinics of North America, 57:1277–90PubMedGoogle Scholar
  18. Dipchand, A., Ellis, G., Petric, M., Poon, A.O. (1997). Laboratory Reference Values. In Dipchand A. (ed.) The HSC Handbook of Pediatrics, 9th edn,. pp. 507–556. Toronto: MosbyGoogle Scholar
  19. Ellerhost-Ryan, J.M. (1993). Infection. In Groenwail S. L., Frogge M.H., Goodman M. (eds) Cancer Nursing: Principles and Practices, pp. 557–554. Boston: Jones and BartlettGoogle Scholar
  20. Engelfriet, C.P., Resink, H.W., Aster, R.H, et al. (1997). Management of alloimmunized refractory patients in need of platelet transfusions. Vox Sang, 73:191–198PubMedGoogle Scholar
  21. Eraklis, A.J., Kevy, S.V., Diamond, L.K., et al. (1967). Hazard of overwhelming infection after splenectomy in childhood. New England Journal of Medicine, 276:1225–30PubMedGoogle Scholar
  22. Fisher, R.J., DeVita, V.T., Bostick, F. (1980). Persistent immunological abnormalities in long term survivors of advanced Hodgkin’s disease. Annals of Internal Medicine, 92:595–598PubMedGoogle Scholar
  23. Greenbaum, B.H. (1991). Transfusion associated graft-verseshost disease: historical perspectives, incidence, and current use of irradiated blood products. Journal of Clinical Oncology, 9:1889–1902PubMedGoogle Scholar
  24. Groll, A.H., Irvin, R.S., Lee, J.W., et al. (2001). Management of specific infectious complications in children with leukemias and lymphomas. In Patrick C.C. (ed) Clinical Management of Infections in Immunocompromised Infants and Children, pp. 111–143. Philadelphia: Lippincott Williams & WilkinsGoogle Scholar
  25. Gunter, K.C., Luban, N.L. (1996). Transfusion transmitted cytomegalovirus. In Rossi E.C., Simm T.L., Moss G.S., Gould S.A. (ed.) Principles of Transfusion Medicine, pp. 717–73). Baltimore: Williams & Wilkins.Google Scholar
  26. Hambleton, J., George, J. (2003). Hemostasis and thrombosis. In George J.N., Williams M.E. (eds) ASH-SAP American Society of Hematology Self Assessment Program, pp. 249–288. Massachusetts: BlackwellGoogle Scholar
  27. Hann, I. (1999). Management of infection in children with bone marrow failure. In. Lilleyman J.S., Hann I.M., Blanchette V.S. (eds) Pediatric Hematology, 2nd edn., pp. 759–767. London: Churchill LivingstoneGoogle Scholar
  28. Hersh, E., Gutterman, J., Mavligit, G.M. (1976). Effect of haematologic malignancies and their treatment on host defense factors. Clinical Haematology, 5:425–30Google Scholar
  29. Hughes, B.S., Armstrong, D., et al. (1990). Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Journal of infectious Diseases, 161:381–383PubMedGoogle Scholar
  30. Hume, H.A. (1999). Blood components: preparation, indications and administration. In Lilleyman J.S., Hann I.M., Blanchette V.S. (eds) Pediatric Hematology, 2nd edn., pp. 629–649. London: Churchill LivingstoneGoogle Scholar
  31. Ingram, J., Weitzman, S., et al. (1991). Complications of indwelling venous access lines in pediatric hematology patients: a prospective comparison of external venous catheters and subcutaneous ports. American Journal of Pediatric Hematology Oncology, 13:130–136Google Scholar
  32. Kicker, T., Braine, H.G., Piantadosi, S., et al. (1990). A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenia. Blood, 75:313–316PubMedGoogle Scholar
  33. Kitchens, C.S. (1995). Disseminated intravascular coagulation. In Brian M.C., Carbone P.P., Kelton J.G., et al. (eds) Current Therapy in Hematology-Oncology, pp. 182–187. St. Louis: MosbyGoogle Scholar
  34. Kline, N.E. (2002). Prevention and treatment of infections. In Baggott C. Rasco, Kelly K. Patterson, Fochtman D., Foley G.V. (eds) Nursing Care of Children and Adolescents with Cancer, 3rd edn., pp. 266–278. Philadelphia: W.B. SaundersGoogle Scholar
  35. Lange, B., O’Neill, J., Goldweinfi, J., et al. (1997). Oncologic emergencies. In Pizzo P.A., Poplack D.G. (eds) Principles and Practices of Pediatric Oncology, 3rd edn., pp. 1025–1049. Philadelphia: Lippincott-RavenGoogle Scholar
  36. Leibovitz, E, Rigaud, M., et al. (1990). Pneumocystis carinii pneumonia in infants infected with the HIV virus with more than 450 CD4 t lymphocytes per cubic millimeter. New England Journal of Medicine, 323:531–533PubMedGoogle Scholar
  37. Lodha, A. (2003). Laboratory reference values. In Cheng A., Williams B.A., Sivarajan V.B. (eds) The HSC Handbook for Pediatrics, 10th edn. pp. 813–898. Toronto: Elsevier CanadaGoogle Scholar
  38. Luban, A.L., Pisciotta, A., Manno, C. (1999). Hazards of transfusion. In Lilleyman J.S., Hann I.M., Blanchette V.S. (eds) Pediatric Hematology, 2nd edn., pp. 741–757. London: Churchill LivingstoneGoogle Scholar
  39. Mackall, C.L., Fleissher, T.A., Brown, M.R., et al. (1995). Age, thymopoiesis and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New England Journal of Medicine, 332:143–149PubMedGoogle Scholar
  40. Metha, S., MacPhee, S. (2003). Emergencies. In Cheng A., Williams B.A., Sivarajan V.B. (eds) The HSC Handbook for Pediatrics, 10th edn. pp. 1–38. Toronto: Elsevier CanadaGoogle Scholar
  41. Murphy, M.F, Metcalfe, P., Ord, J., et al. (1987). Disappearance of HLA and platelet-specific antibodies in acute leukemia patients alloimmunized by multiple transfusions. British Journal of Haematology, 67:255–260PubMedGoogle Scholar
  42. Ozer, H., Armitage, J.O., Bennett, C.L., et al. (2000). 2002 Update of recommendations for the use of hematopoietic colony-stimulation factors: evidence-based, clinical practice guideline. Journal of Clinical Oncology, 18:3558–3585PubMedGoogle Scholar
  43. Panzarella, C., Rasco Baggott, C., Comeau, M, et al.(2002). Management of Disease and treatment-related complications. In Baggott C. Rasco, Kelly K. Patterson, Fochtman D., Foley G.V. (Eds), Nursing Care of Children and Adolescents with Cancer, 3rd edn., pp. 279–318. Philadelphia: W.B.SaundersGoogle Scholar
  44. Parsons, S.K., Mayer, D.K., Alexander, S.W. et al. (2000). Growth factor practice patterns among pediatric oncologist; results of a 1998 Pediatric Oncology Group survey: Economic evaluation working group the Pediatric Oncology Group. Journal of Pediatric Hematology Oncology, 22:227–241Google Scholar
  45. Pizzo, P.A. (1989). Considerations for the prevention of infectious complications in patients with cancer. Review of Infectious Disease, 11(Suppl. 7):S1551Google Scholar
  46. Pizzo, P.A. (1993). Management of fever in patients with cancer and treatment induced neutropenia. New England Journal of Medicine, 328:1323–1332PubMedGoogle Scholar
  47. Pizzo, P.A., Mueller, B.U. (1998). Infectious complications in children with hematologic disorders. In Nathan D.A., Orkin S.H. (eds) Nathan and Oski’s Hematology of Infancy and Childhood, 5th edn., pp. 1738–1759. Philadelphia: W.B. SaundersGoogle Scholar
  48. Przepiorka, D., LeParc, G. F., Werch, J., et al. (1996). Prevention of transfusion associated cytomegalovirus infection: practice parameter. American Journal of Clinical Pathology, 106:163–169PubMedGoogle Scholar
  49. Riikonen, P, Saarinen, N.M., et al. Management of indwelling venous catheters in pediatric cancer patients with fever and neutropenia. Scandinavian Journal of Infectious Disease, 25:357–360Google Scholar
  50. Rizzo, J.D, Lichtin, A.L., Woolf, S.H., et al. (2002). Use of Epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Journal of Clinical Oncology, 20:4083–4107PubMedGoogle Scholar
  51. Rosse (1987). The spleen as a filter. New England Journal of Medicine, 317:705–706Google Scholar
  52. Rouse, B.T., Horohov, D.H. (1986). Immunosuppression in viral infections. Review of Infectious Disease, 8:850–855Google Scholar
  53. Rubin, R.H., Ferraro, M.J. (1993). Understanding and diagnosing infectious complications in the immunocompromised host: Current issues and trends. Hematology/Oncology Clinics of North America, 7:795–811PubMedGoogle Scholar
  54. Santos, J.I. (1994). Nutrition, infection and immunocompetence. Infectious Disease. Clinics of North America, 8:243–50Google Scholar
  55. Sayer, M.H., Anderson, K.C., Goodnough, L.T., et al. (1992). Reducing the risk for transfusion-transmitted cytomegalovirus. Annals of Internal Medicine, 116:55–62PubMedGoogle Scholar
  56. Schiffer, C.A., Anderson, K.C., Bennett, C.L., et al. (2003). Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19:1519–1538)Google Scholar
  57. Shamsah, A. (2003). Hematology. In Cheng A., Williams B.A., Sivarajan V.B. (eds) The HSC Handbook for Pediatrics, 10th edn., pp. 350–378. Toronto: Elsevier CanadaGoogle Scholar
  58. Slichter, S.J. (1990). Mechanisms and management of platelet refractoriness. In Nance S.T. (ed) Transfusion Medicine in the 1990s, pp. 95–179. Arlington: American Association of Blood BankGoogle Scholar
  59. Spirer, Z., Zakuth, V, Diamant, S., et al. (1977). Decreased tuftsin concentration in patients who have undergone splenectomy. British Medical Journal, 2:1574–1576PubMedGoogle Scholar
  60. Steele, M. (2003). Oncology. In Cheng A., Williams B.A., Sivarajan V.B. (eds) The HSC Handbook for Pediatrics, 10th edn., pp. 609–639. Toronto: Elsevier CanadaGoogle Scholar
  61. Strauss, R.G. (1994). Granulocyte transfusion therapy. In Mintz P.D. (ed). Transfusion medicine 1. Hematology Oncology Clinics of North America, 8:1159–1166Google Scholar
  62. Thatcher, N., DeCampos, E.S., Bell, D.R., et al. (1999). Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum based chemotherapy for small cell lung cancer. British Journal of Cancer, 80:396–402PubMedGoogle Scholar
  63. Vogelsang, G.B, Hess, A.D. (1994). Graft-versus-host disease: new directions for a persistent problem. Blood, 84:2061–2067PubMedGoogle Scholar
  64. Walsh, T.J. (1993). Management of immunocompromised patients with evidence of invasive mycosis. Hematology Oncology Clinics of North America, 7:1003–1008Google Scholar
  65. Walsh TJ, Pizzo PA (1988) Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annual Review of Microbiology 42:517–45PubMedGoogle Scholar
  66. Wilson, K.D. (2002). Oncologic emergencies. In Baggott C. Rasco, Kelly K. Patterson, Fochtman D., Foley G.V. (eds) Nursing Care of Children and Adolescents with Cancer, 3rd edn., pp.334–346. Philadelphia: W.B. SaundersGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Sandra Doyle

There are no affiliations available

Personalised recommendations